Patent · US Active

Compositions and dosage forms for treatment of HPV infection and HPV-induced neoplasia

US12329768B2 · kind B2 · utility

0Cited by

85References

10Claims

0Family size

Assignee

Antiva Biosciences, Inc. · US

Inventors

Barry Aldous · Brisbane, US
Ramakrishna Gadiraju · Foster City, US
Ankush Argade · Foster City, US
Zhengle Zhao · Shanghai, CN
Siyi Jiang · Shanghai, CN
Runyan Li · Shanghai, CN
Chao Liu · Heverlee, BE
Minyan Liu · Lanzhou, CN

Key dates

Filing date	Oct 31, 2023
Grant date	Jun 17, 2025
Priority date	—
Expiry date	Oct 31, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/65616
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.